ArticleFrontiers in psychiatry2025
Verbal memory in major depressive disorder in a long-term perspective: a five-year longitudinal study of first episode patients.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Major depressive disorder (MDD) is associated with cognitive impairment, including verbal memory. Limited knowledge exists following memory performance in first episode (FE) MDD. This study investigated verbal memory, depressive symptoms, and relapse in FE MDD over five years, from the trait, state, and scar perspectives. These perspectives suggests that deficits in memory either preexists, manifest in MDD, or exacerbates with every MDD episode, respectively. Methods: Thirty patients and 30 healthy matched controls (HC) were assessed using the California Verbal Learning Test, second edition (CVLT-II) across three test occasions; in the acute phase (Y0), at one-year (Y1) and five-year (Y5) follow-up. The relationship between CVLT-II scores and depression severity (measured by the Montgomery Åsberg Depression Rating Scale) and relapse at the five-year follow-up, was assessed. Results: The FE MDD group demonstrated significantly poorer performance on List A, Trial 1 immediate free recall at Y0 compared to HC, however correction for multiple comparisons the difference did not reach significance. No differences were observed in any other condition at any time point. Further, the PG had a significant improvement on List A, trial 1 from Y0 to Y5. No associations were found between symptom severity and verbal memory, and no performance differences were identified between patients with and without relapse in a five -year perspective. Discussion: In conclusion, individuals with FE MDD show normal verbal memory performance, but exhibit impaired performance on List A, Trial 1 immediate free recall in the acute phase improving in remission, indicative of a state-related deficit in auditory attention. No evidence of scarring deficits in the FE MDD group was observed in the follow-up period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.